Through empowering and educating patients, funding cutting-edge research, building strategic collaborations and raising public awareness, our goal is to transform lung cancer into a chronically managed disease within 10 years and ultimately to find a cure.

Latest News
Patient value: Perspectives from the advocacy communityPatient value: Perspectives from the advocacy community // The paradigm of decision making for healthcare must change. It is imperative that patients are part of the equation. According to this article, co-authored by Bonnie J. Addario, “There is... Read More READ MORE
Calling All ArtistsCalling All Artists // ALCF is holding a t-shirt design contest! Get your creative juices flowing while supporting lung cancer. The winning design will be on t-shirts for the entire 2018 Your Next Step... Read More READ MORE
Patient Advocacy Strategies Evolve as Genomic Advances Change Understanding of CancerPatient Advocacy Strategies Evolve as Genomic Advances Change Understanding of Cancer // The ROS1ders, are throwing their energy behind creating preclinical mouse models and cells lines that will inform drug development efforts and improve understanding... Read More READ MORE
ALCMI, Champions Oncology, and ROS1ders to Launch Clinical StudyALCMI, Champions Oncology, and ROS1ders to Launch Clinical Study // The Addario Lung Cancer Medical Institute (ALCMI), and Champions Oncology (NASDAQ: CSBR), a company engaged in the development and sale of advanced technology solutions and products to personalize the development... Read More READ MORE
Lung Cancer Early Detection Challenge: Concept to ClinicLung Cancer Early Detection Challenge: Concept to Clinic // Looking for data scientists, software engineers, designers and researchers to build an open source software application that puts advances from machine learning into the hands of practicing clinicians. In addition... Read More READ MORE